BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 28103585)

  • 1. Long non-coding RNAs in osteosarcoma.
    Chen R; Wang G; Zheng Y; Hua Y; Cai Z
    Oncotarget; 2017 Mar; 8(12):20462-20475. PubMed ID: 28103585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Noncoding RNA EWSAT1 Promotes Osteosarcoma Cell Growth and Metastasis Through Suppression of MEG3 Expression.
    Sun L; Yang C; Xu J; Feng Y; Wang L; Cui T
    DNA Cell Biol; 2016 Dec; 35(12):812-818. PubMed ID: 27860482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A long non-coding RNA contributes to doxorubicin resistance of osteosarcoma.
    Zhang CL; Zhu KP; Shen GQ; Zhu ZS
    Tumour Biol; 2016 Feb; 37(2):2737-48. PubMed ID: 26408180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profiling of long noncoding RNAs associated with vasculogenic mimicry in osteosarcoma.
    Ren K; Ni Y; Li X; Wang C; Chang Q; Li Y; Gao Z; Wu S; Shi X; Song J; Yao N; Zhou J
    J Cell Biochem; 2019 Aug; 120(8):12473-12488. PubMed ID: 30825232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA HOTTIP is up-regulated and associated with poor prognosis in patients with osteosarcoma.
    Li F; Cao L; Hang D; Wang F; Wang Q
    Int J Clin Exp Pathol; 2015; 8(9):11414-20. PubMed ID: 26617868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA CTA sensitizes osteosarcoma cells to doxorubicin through inhibition of autophagy.
    Wang Z; Liu Z; Wu S
    Oncotarget; 2017 May; 8(19):31465-31477. PubMed ID: 28415557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNAs: emerging players in osteosarcoma.
    Li Z; Yu X; Shen J
    Tumour Biol; 2016 Mar; 37(3):2811-6. PubMed ID: 26718212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of Long Noncoding RNAs in Osteosarcoma: Biomarkers and Therapeutic Targets.
    Li Z; Dou P; Liu T; He S
    Cell Physiol Biochem; 2017; 42(4):1407-1419. PubMed ID: 28715796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA BLACAT1 accelerates the proliferation and migration of osteosarcoma cells through regulating STAT3.
    Dong Z; Wang Y
    Pathol Res Pract; 2019 Mar; 215(3):571-579. PubMed ID: 30665678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA EPIC1 inhibits viability and invasion of osteosarcoma cells by promoting MEF2D ubiquitylation.
    Zhao W; Zhang D; Qin P; Zhang J; Cui X; Gao J; Wang J; Li J
    Int J Biol Macromol; 2019 May; 128():566-573. PubMed ID: 30703420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNAs in the progression, metastasis, and prognosis of osteosarcoma.
    Yang Z; Li X; Yang Y; He Z; Qu X; Zhang Y
    Cell Death Dis; 2016 Sep; 7(9):e2389. PubMed ID: 27685633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of long noncoding RNA CCAL predicts poor patient prognosis and promotes tumor metastasis in osteosarcoma.
    Zhou DK; Yang XW; Li H; Yang Y; Zhu ZJ; Wu N
    Int J Biol Markers; 2017 Mar; 32(1):e108-e112. PubMed ID: 28009431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA expression profiles of the doxorubicin-resistant human osteosarcoma cell line MG63/DXR and its parental cell line MG63 as ascertained by microarray analysis.
    Zhu KP; Zhang CL; Shen GQ; Zhu ZS
    Int J Clin Exp Pathol; 2015; 8(8):8754-73. PubMed ID: 26464619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered long non-coding RNAs predict worse outcome in osteosarcoma patients: evidence from a meta-analysis.
    Yang Y; Wang S; Li T
    Oncotarget; 2017 May; 8(21):35234-35243. PubMed ID: 28415638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA tumor suppressor candidate 7 functions as a tumor suppressor and inhibits proliferation in osteosarcoma.
    Cong M; Li J; Jing R; Li Z
    Tumour Biol; 2016 Jul; 37(7):9441-50. PubMed ID: 26781978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LINC00324 accelerates the proliferation and migration of osteosarcoma through regulating WDR66.
    Wu S; Gu Z; Wu Y; Wu W; Mao B; Zhao S
    J Cell Physiol; 2020 Jan; 235(1):339-348. PubMed ID: 31225659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential regulatory role of lncRNA-miRNA-mRNA axis in osteosarcoma.
    Wang JY; Yang Y; Ma Y; Wang F; Xue A; Zhu J; Yang H; Chen Q; Chen M; Ye L; Wu H; Zhang Q
    Biomed Pharmacother; 2020 Jan; 121():109627. PubMed ID: 31810120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of lncRNA HULC indicates a poor prognosis and promotes cell metastasis in osteosarcoma.
    Sun XH; Yang LB; Geng XL; Wang R; Zhang ZC
    Int J Clin Exp Pathol; 2015; 8(3):2994-3000. PubMed ID: 26045809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel long non-coding RNA, hypoxia-inducible factor-2α promoter upstream transcript, functions as an inhibitor of osteosarcoma stem cells in vitro.
    Wang Y; Yao J; Meng H; Yu Z; Wang Z; Yuan X; Chen H; Wang A
    Mol Med Rep; 2015 Apr; 11(4):2534-40. PubMed ID: 25434862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIF‑1α‑induced upregulation of lncRNA UCA1 promotes cell growth in osteosarcoma by inactivating the PTEN/AKT signaling pathway.
    Li T; Xiao Y; Huang T
    Oncol Rep; 2018 Mar; 39(3):1072-1080. PubMed ID: 29328452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.